Naproxen on Tooth Sensitivity Caused by In-office Bleaching

• Status: Completed
• Trial end date: 2016-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to evaluate the effects of prior use of non-steroidal anti-inflammatory Naproxen on risk and level of tooth sensitivity caused by in-office bleaching procedures.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Universidade Federal de Sergipe
• Treatments: Naproxen

Criteria

Inclusion Criteria:

• At least 18 years old patients of both genders presenting good general/oral health;

• All maxillary anterior teeth presenting shade equal or darker than 2M2 at Vita bleachguide guide (Vita-Zahnfabrik, Germany);

• Signed the form accepting to participate of this study.

Exclusion Criteria:

• Presence of caries lesions, restorations and/or endodontic treatment at any maxillary anterior teeth.

• Undergone tooth-whitening procedures;

• Pregnant/lactating;

• Presence of periodontal diseases;

• Presence of severe tooth discoloration by tetracycline stains or fluorosis;

• Any kind of medicine, bruxism habits or any other pathology that can cause sensitivity (such as recession, dentin exposure);

• Continuous use of drugs with anti-inflammatory actions;

• Presence of tooth hypersensitivity at baseline measurement;

• Any known adverse effects caused by Naproxen;

• Non-attendance to any session of evaluation or bleaching.